That ressource is reserved for health professionals

This space contains information on medical devices, the use of which is reserved for healthcare professionals. In application of the law of December 29, 2011 relating to the strengthening of health security, I certify that I am a health professional and therefore be authorized to access this information.

I am a healthcare professional


Close window if you are not a healthcare professional


Close menu



Durvalumab - Labelled (Arg,Lys) 13C15N


Quantification of Durvalumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Durvalumab is a recombinant, full length stable isotope labelled monoclonal antibody designed for use as an internal standard for quantitative analysis of Durvalumab in plasma samples. Durvalumab targets the immune checkpoint programmed death-ligand1 (PD-L1) and is used to treat a number of cancers

This product is for research use only and is not intended for diagnostic or therapeutic use.